without any significant obstetric problems. After the last birth she had a prolonged lactation lasting two years (more than 18 months after the child had been weaned); this episode remitted spontaneously, the patient receiving no medication. This period of galactorrheea was followed by severe cyclical edema, with weight gain of 5-10 kg and abnormal thirst, during the luteal phase of each cycle; she took diuretics intermittently to relieve the cedema. Investigations: The patient was admitted to hospital and it was found that she retained sodium, potassium and water during the premenstrual phase (Fig 1) . Plasma prolactin concentrations (at 9 a.m.) during the follicular phase were 5.25 ± 1.7 ng/ml (n==4) and were significantly higher (P<0.05) during the luteal phase -10.25 ± 2.5 ng/ml (n=8) by radioimmunoassay (Cole & Boyns 1973) (1 ng=0.02 milliunits MRC Res. Std. A Prolactin 71/222). Plasma renin activity (Dr R Wilkinson) during the follicular phase was 34 ng/l/min lying and 31.7 ng/l/min standing (normal), and was suppressed below the limit of detection of the assay (3 ng/l/min) during the luteal phase.
The cyclical pattern of gonadotrophin and oestrogen excretion was normal throughout the cycle. Thyroid and adrenal function normal.
Pituitary fossa of normal size radiologically. Renal function and plasma protein concentrations normal. Treatment and progress: Lithium carbonate (Sletton & Gershon 1966) was started and the serum lithium concentration was maintained between 0.5 and 1.0 mEq/l. There was striking symptomatic improvement for about six months and in November 1973, during a further admission to hospital, the patient was found to be in sodium and water balance throughout the luteal phase of the cycle. Plasma prolactin concentrations during the luteal phase were 21.75±4.9 ng/ ml (n=12) and were significantly higher than before treatment (P<0.01). Lithium therapy proved progressively less effective over the next three months, the cyclical cedema returned and the patient started to take diuretics again.
Lithium was discontinued and in April 1974 treatment was started with 2-bromo-a-ergocryptine (bromocriptine, CB154 Sandoz), 2.5 mg This completely relieved the cyclical cedema over an eleven-month period. Luteal phase prolactin levels were 7.7 (s.d.±2.1) ng/ml (n=12) during therapy and these values were significantly lower than the pretreatment values (P<0.05). The patient's weight fluctuated by less than 1 kg during the cycle and further investigation demonstrated that she was in fluid balance. Plasma renin levels were normal during the luteal phase of the cycle (21 and 17 ng/l/min lying, 19 and 31 ng/l/min standing).
Comment 'Idiopathic' cedema is a common, but ill-defined, condition which has been recognized for more than half a century. It affects women during the reproductive phase of life and is commonly but not invariably worse in the premenstrual phase.
(Minor degrees of fluid retention are generally considered to be 'physiological'.) Patients are frequently obese and emotional lability may be common (Lancet 1972) .
The possible relationship of this patient's cyclical cedema to an abnormality of prolactin secretion was considered in view of the past history of galactorrhcea and the knowledge that prolactin can cause renal retention of sodium and water (Horrobin et al. 1971 ). Most women show little change in plasma prolactin concentration between the follicular and luteal phases (Friesen & Hwang 1973) ; but in this patient it was significantly higher in the luteal than in the follicular phase. A substantial reduction of plasma prolactin levels by 2-bromo-a-ergocryptine was associated with complete relief of premenstrual fluid and electrolyte retention; this suggests that prolactin may play a part in the development of 'idiopathic cedema' in some patients, and warrants further study. The reduction in plasma renin activity to undetectable levels during the luteal phase suggested that the renin-angiotensinaldosterone mechanism played no part in the observed changes and was secondarily suppressed by some other fluid and electrolyte retaining substance. Since bromocriptine is a doparnine agonist, and dopamine can cause renal fluid and electrolyte excretion, this might account for part of its action in our patient.
The patient's initial response to lithium therapy is noteworthy. Lithium has major effects in many organs, particularly those involved with ion transport and polypeptide hormone action. It has been suggested that lithium exerts its actions by incomplete ion substitution and by interfering with cAMP processes that are regulated by polypeptide hormones (Singer & Rotenberg 1973 , Forrest et al. 1974 ). It seems likely, therefore, that lithium interferes with the renal actions of pro-lactin, and that the initial good clinical response in this patient was lost when the prolactin levels during the luteal phase rose to very high levels, thus overcoming the antagonism by lithium. C P, woman aged 46. Housewife History: January 1975: developed cough, myalgia and malaise, received oxytetracycline. Four days after onset started nausea, vomiting and diarrhoea. Three days later suffered two grand mal fits, leading to hospital admission. It was later learnt that she had been investigated for primary amenorrhoea in 1951, when small uterus, atrophic endometrium and low 17 oxosteroid excretion were disclosed. Pituitary fossa and BMR were normal. She was treated with a course of stilbcestrol. She had lived in Russia until her teens and had recently married. On examination: Skin cool, pale and fine in texture. Pubic and axillary hair absent, breasts poorly developed. Pulse 60/min, BP 130/80 mmHg. Visual fields full to confrontation, fundi normal. Transitory left pyramidal signs, tendon jerks showed slow relaxation. There was no meningism. Initial investigations: Skull X-ray normal. Chest X-ray scarred right upper zone. Hb 10.9 g/100 ml. WBC 4000 mm-3. Plasma sodium 108 mmol/l (normal 136-147), potassium 3.4 mmol/l (normal 3.8-5.2), bicarbonate 24 mmol/l (normal 20-30), urea 3.0 mmol/l (normal 2.5-6.5), cortisol 0.18 pmol/l (low), blood sugar 4.9 mmol/l (normal 3.2-10.0). Management: It was considered that longstanding hypopituitarism had been exacerbated by infection, leading to water intoxication and fits. She was given 1 litre 2N saline (NaCl 308
